Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Plasma cell 2Breast 2Other hematologic neoplasm 1Genitourinary 1

Conditions

Breast Neoplasms 70Neoplasm Metastasis 11Prostatic Neoplasms 9Pain 8Osteoporosis 8Multiple Myeloma 5Humoral Hypercalcemia Of Malignancy 4Triple Negative Breast Neoplasms 3Bone Diseases, Metabolic 3Neoplasms 2Lung Neoplasms 2Breast Neoplasms, Male 2Bone Neoplasms 2Bone Diseases 2Renal Insufficiency 1Ovarian Neoplasms 1Neovascularization, Pathologic 1Neoplastic Cells, Circulating 1Neoplasms by Site 1Neoplasm Micrometastasis 1Metastatic Breast Cancer With Bone Involvement 1Hereditary Breast and Ovarian Cancer Syndrome 1Fractures, Bone 1Fatigue 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Diseases 1Breast Cancer Metastatic 1

Interventions

Zoledronic Acid 2Vitamin D 2saracatinib 1odanacatib 1Progestins 1Hormone Replacement Therapy 1Estrogens 1Estrogen Replacement Therapy 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Diseases × Zoledronic Acid × Breast × Clear all
NCT00399802 2018-08-16

A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

Merck Sharp & Dohme LLC

Phase 2 Completed
43 enrolled 10 charts
Breast

Bone Diseases, Breast Neoplasms

NCT00558272 2013-05-27

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

AstraZeneca

Phase 2 Completed
139 enrolled 23 charts
BreastGenitourinarySarcoma

Bone Diseases, Bone Neoplasms, Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡